Susquehanna Fundamental Investments, LLC Acorda Therapeutics Inc Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.53 $6,554 - $11,978	-22,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.3 - $4.71 $2,760 - $5,652	-1,200 Reduced 5.04%	22,600 $54,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.79 $79,968 - $114,002	23,800 New	23,800 $109,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.